Comprehensive review of 1,300 transaction trends, key players, top

0

DUBLIN – (BUSINESS WIRE) – The report “Global Precision Medicine Partnering Terms and Agreements 2014-2021” has been added to ResearchAndMarkets.com offer.

The Global Precision Medicine Partnering Terms and Agreements 2014-2021 report provides full access to available offerings and contract documents for over 1,300 Precision Medicine offerings.

The report presents the reader with a comprehensive review of Precision Medicine deal trends, key players, key deal values, and deal financial data, providing an understanding of how, why, and under what terms, companies enter into deals. in partnership with Precision Medicine.

The report presents the terms of financial agreements values ​​for Precision Medicine agreements, listing by aggregate value, upfront payments, milestone payments, and royalties, allowing readers to analyze and compare the financial value of agreements.

The central section of the report explores the key negotiators in the area of ​​precision medicine partnerships; the values ​​of the most important transactions and the most active precision trading companies are reported, allowing the reader to see who is successful in this dynamic trading marketplace.

One of the highlights of the report is that over 1,300 online agreement files of actual precision medicine agreements, as disclosed by the parties to the agreement, are included towards the end of the report in a format. directory – by AZ company, stage of development, type agreement, therapeutic orientation and type of technology – it’s easy to reference. Each transaction record in the report is linked via a web link to an online version of the transaction.

Additionally, when available, the records include contractual documents as submitted to the Securities Exchange Commission by the companies and their partners. While many companies will be looking for details on payment terms, the devil is in the details of how payments are triggered – contract documents provide that insight where press releases and databases don’t. do not.

The first chapters of this report provide guidance in precision medicine trading. Chapter 1 provides an introduction to the report, while Chapter 2 provides an overview of trends in precision medicine transactions since 2014, including details on the terms of the title, advance, milestones and royalties.

Chapter 3 reviews the major precision medicine offerings since 2014. The offerings are listed by aggregate value. When the deal has a deal contract published to the SEC, a link provides online access to the contract.

Chapter 4 provides a comprehensive list of Top 25 Companies most active in Precision Medicine transactions with a brief summary followed by a full list of Precision Medicine transactions advertised by this company along with contractual documents where applicable. .

Chapter 5 provides a comprehensive and detailed review of the Precision Medicine Partnership Agreements signed and announced since January 2014, where a contractual document is available in the public domain. Each transaction title is linked via a web link to an online version of the transaction record and contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive and detailed review of the precision medicine partnership agreements signed and announced since January 2014. The chapter is organized by specific precision medicine technology type. Each transaction title is linked via a web link to an online version of the transaction record and, if applicable, the contract document, providing easy access to each transaction on demand.

A full set of appendices are provided, organized by partner company Precision Medicine AZ, stage of development, type of agreement, and direction of therapy. Each transaction title is linked via a web link to an online version of the transaction record and, if applicable, the contract document, providing easy access to each transaction on demand.

Key Benefits

The 2014-2021 Precision Medicine Global Partnership Terms and Agreements provide the reader with the following key benefits:

  • In-depth understanding of precision medicine chord trends since 2014

  • Access to title, advance, milestone and royalty data

  • Detailed access to real precision medicine contracts concluded by major biopharmaceutical companies

  • Identify the most active dealmakers in precision medicine since 2014

  • Overview of terms included in a precision medicine partnership agreement, with real-world examples

  • Understand the key terms of agreements that companies have agreed to in previous agreements

  • Undertake due diligence to assess the adequacy of the terms of your proposed agreement for partner companies

Precision Medicine Partnership Terms and Agreements include:

  • Trends in precision medicine transactions in the biopharmaceutical industry since 2014

  • Analysis of the transaction structure of Precision Medicine

  • Access to title, advance, milestone and royalty data

  • Access to precision medicine contractual documents

  • Main precision medicine contracts by value since 2014

  • Most active precision medicine negotiators since 2014

In the 2014-2021 Precision Medicine Global Partnership Terms and Agreements, available offerings are listed by:

  • Company from A to Z

  • Title value

  • Stage of development at signing

  • Component type of the agreement

  • Specific therapeutic target

  • Type of technology

For more information on this report, visit https://www.researchandmarkets.com/r/v0j3ht

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Director

press@researchandmarkets.com

For EST office hours, call 1-917-300-0470

For USA / CAN call toll free 1-800-526-8630

For GMT office hours, call + 353-1-416-8900

Copyright © acrofan / Business Wire All rights reserved


Source link

Share.

Comments are closed.